Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the stock. Other equities research analysts have also issued reports about the stock. Zacks Investment Research lowered shares of Chembio Diagnostics from a “hold” rating […]